Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
M. Paats (Rotterdam, Netherlands). Modern staging in lung cancer: from the current multidisciplinary process to novel approaches. International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach

Member's Comments

No comment yet.

Related content which might interest you: The effectiveness of a multidisciplinary approach in the management of lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 495s Year: 2005 New treatment concepts in stage IV non-small cell lung cancer: personalised multidisciplinary approaches Source: Virtual Congress 2021 – Thoracic oncology Year: 2021 Evolution in the diagnostic approach to lung cancer Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 New treatment concepts in stage IV NSCLC: personalized multidisciplinary approaches Source: Virtual Congress 2021 – Hot topics in thoracic oncology Year: 2021 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 From staging to therapy: implications of the new staging system with a focus on multi-modal treatment options Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Practical tools for implementing early palliative care in advanced lung cancer Source: Eur Respir J 2016; 47: 1010-1012 Year: 2016 Mediastinal staging in lung cancer: A rational approach Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 PG11 Modern approaches in lung cancer diagnostics and therapy Source: Paris 2018 - Educational material Year: 2018 Biomarkers in early-detection of lung cancer: current concepts Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts Year: 2021 Implications of new lung adenocarcinoma classification for oncologists Source: Annual Congress 2009 - The new ERS/ATS/IASLC classification of lung adenocarcinoma: practice update Year: 2009 Early origins of lung disease: towards an interdisciplinary approach Source: Eur Respir Rev, 29 (157) 200191; 10.1183/16000617.0191-2020 Year: 2020 Modern profiling of advanced lung cancer at the primary diagnosis and during therapy Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer Year: 2018 New and anticipated therapeutic developments in management of non-small-cell lung cancer Source: Annual Congress 2013 –ERS/The Lancet/The Lancet Respiratory Medicine joint Lunchtime session on lung cancer Year: 2013 The ALA/ATS implementation guide on lung cancer screening Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016 What the radiologist can offer - the latest imaging and evaluation techniques for lung cancer screening and comorbidities Source: International Congress 2018 – Lung cancer screening and management of solitary pulmonary nodules Year: 2018